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Abstract: A practically useful coupling reaction between aromatic 
halides and redox-active esters was realized via nickel catalysis 
through the use of packed zinc bed column in continuous flow. 
Multiple reuse of the column showed a negligible decrease in 
efficiency, affording high space/time yields. A wide range of 
substrates, including a number of heteroaryl halides and 
polyfunctional materials were coupled in generally good yields. 
Longer-time and larger-scale experiments further demonstrates the 
robustness of the system.   
Developing molecular complexity is an important aspect of 
modern drug discovery programs and has been associated with 
success in progressing compounds into clinical development[1] by 
improving target selectivity[2] and safety.[3] Increasing the number 
of sp3 centers similarly enhances the three-dimensional 
complexity, again improving success rates.[4] As a consequence，
practical and simple methods to construct C(sp3)-C(sp2) bonds 
are of fundamental importance.[5] A seminal contribution to this 
field was reported by MacMillan and Doyle who utilized an Ir-
photoredox/Ni dual catalyst system to achieve decarboxylative 
C(sp3)-C(sp2) cross coupling (Figure 1).[6] In this reaction, the 
synergistic combination of photoredox catalysis and nickel 
catalysis forges 3D-rich structures from simple and readily 
available organic molecules. More importantly, carboxylic acid 
starting materials have a higher accessibility compared to other 
conventional cross-coupling partners.[7] Following this pioneering 
report, synthetic methods that enable medicinal chemists to 
generate C(sp3)-enriched compounds by these decarboxylative 
pathways have been widely explored.[8] Among these alternative 
approaches, Weix et. al reported the use of zinc powder as a 
reducing reagent,[9] therefore avoiding expensive iridium 
catalysts,[6] or the need for preformed pyrophoric organozinc 
reagents[10] and photo-/electrochemical reactors.[8c, 8d, 11] More 
recently, Fier et. al also described a metallic zinc mediated cross-
coupling reaction between aryl bromides and redox-active alkyl 
sulfones.[12] Despite the relevance and the effectiveness of these 
discoveries, activated zinc powder can be challenging to work 
with on large scales mainly due to issues of surface variation and 
safety.[13] Given our expertise in continuous processing 
methods,[14] and with the availability of newly developed flow 
columns packed with metallic zinc,[15] we decided to further 
explore their deployment in cross-coupling sequences. We 
believe using zinc bed columns to be superior to typical batch 
procedures for several reasons, especially avoiding excessive 
use of zinc powder, problems during downstream processing and 
the difficulty of controlling exothermic reactions. Here, we report 
a simple, practical improvement to general nickel-catalyzed 
decarboxylative cross-coupling processes by utilizing a zinc bed 
column in a continuous flow system. This robust procedure 
enables access to a wide variety of 3D rich molecules starting 
from versatile (hetero)aryl halides, and redox-active esters which 
are themselves easily prepared from corresponding carboxylic 
acids in flow.  
  
Figure 1. C(sp3)-C(sp2) coupling of redox-active ester and carboxylic acid 
 
Pre-activation of the zinc packed Omnifit® cartridge followed a 
protocol developed by Alcázar et. al,[15] whereby a solution of 
TMSCl and 1-bromo-2-chloroethane in THF was flushed through 
the system (See Supporting Information for detailed procedure). 
Our initial study utilized similar conditions to the batch procedure 
reported by Weix et. al for comparison,[9a] where a mixture of 1-
chloro-4-iodobenzene 1a, redox-active ester 2a together using 
NiCl2 glyme complex and di-tert-butyl-2,2-bipyridine ligand in 
DMAc were passed through a packed zinc (30 mesh) column with 
a residence time of 40 min led to a modest 49% yield of the 
coupled product 3a (Table 1, entry1). Subsequent ligand 
screening highlighted L1 as being superior, giving an improved 
the yield of 98% (entry 2). Encouraged by this success, attempts 
were made to shorten the residence time of the reaction in order 
to achieve a faster overall cross-coupling process. Following on 
an extensive study of residence time and examining various 
grades and combinations of zinc powder (see Supporting 
Information, Table SI1, Figure SI1), using a mixture of 30 and 325 
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mesh of zinc powder successfully reduced the residence time 
(Table 1, entry 3 – 6) to only 10 min. Furthermore, more than 10 
times reuse of the zinc column showed no lost in efficiency (entry 
7). Control experiments demonstrated that both the nickel catalyst 
and the ligand were necessary for reaction to occur (entry 8, 9). It 
is also worth noting that the preparation of reaction mixture does 
not require the use of a glove box or specially dried solvents. The 
shorter reaction time in flow (10 min) to a comparable batch (12 
h) procedure is noteworthy.  
 
Table 1. Reaction Optimisation 
 
entry ligand mesh tR (min) LC yield (%) 
1a 3a 
1 Dtbpy 30 40 32 49 
2 L1 30 40 0 98 
3 L1 30 30 0 100 
4 L1 20 20 14 81 
5 L1 30/325 
(11:2) 
20 4 95 
6a L1 30/325 
(11:2) 
10 0 100 
7b L1 30/325 
(11:2) 
10 0 100 
8 none 30/325 
(11:2) 
10 30 0 
9c none 30/325 
(11:2) 
10 28 0 
a) After 3 times use. b) 10 times use. c) Without nickel catalyst 
Under optimized conditions, we then assessed the scope of the 
reaction with various aryl iodides (Figure 2). Apart from 1-chloro-
4-iodobenzene 1a, 1-bromo-4-iodobenzene 1b also acting as 
suitable reaction partner to afford the corresponding coupled 
product of 3b nicely illustrating the chemoselectivity of the 
process. It is also worth noting that 3b and the boronic pinacol 
ester product 3c, both serve as precursors for future 
diversification through conventional cross-coupling reactions. 
Iodonaphthalene 1d and iodophenanthrene 1e also delivered the 
corresponding products in an excellent 90% and 91% yield 
respectively (3d and 3e). Electron-donating groups such as 4-
iodoanisole 1f and 4-iodothioanisole 1g, which often failed as 
coupling partners for similar nickel catalyzed reductive cross-
coupling reactions, here were able to obtain the desired product 
3f and 3g in good yields.[8c, 8d],[16] Trifluoromethoxy 3h and 
trifluoromethyl product 3i exemplified the tolerance for electron-
withdrawing groups. With respect to functional-group compatibility, 
aryl iodides containing nitrile 1j, ketone 1k, ester 1l, amide 1p and 
phenol 1q functionality, some of which can sometimes be 
problematic in Kumada and Negishi type coupling, were all well-
tolerated under our cross-coupling conditions.[8b] Variations in the 
position of substituents on the phenyl ring led to meta-substituted 
compound 3m with 93% yield, while ortho-coordinating groups, 
such as ester (3n) and phenyl (3o) led to slightly diminished yield 
of 85% and 89% respectively.[16] To further illustrate the 
robustness of the protocol, we found that crude redox-active 
esters, e.g. 3a, prepared from corresponding carboxylic acids  
afforded comparable yields to using the pure isolated active 
esters. 
 Figure 2. Scope on aryl iodides 
Crucial to the success of this method is that heteroaryl halides as 
coupling substrates, including several reactive substrates, were 
well tolerated. The resulting coupled products were obtained in 
good to excellent yields (Figure 3).[17] 4-Iodopyridine derivatives 
(1r-t) all gave the corresponding products in useful yields. Among 
these a gram scale synthesis of 4-(4-piperidinyl)-pyridine 
analogue 3t was achieved, whose structure is frequently found in 
many functional materials but conventionally requires a 4-step 
synthetic sequence from commercially available starting 
materials.[18] The crude product was treated with basic a workup 
followed by a A-15 resin extraction. The desired product was 
acquired in 61% yield with high purity without the need for silica 
gel chromatography. Coupling between 3-iodopyridyl substrates 
(1u-x) and various redox-active esters were all successful (3u-x), 
especially using activated 2-bromo-5-iodopyridine (1v). Although 
in this example a trace of 2-substituted byproduct was detected 
under the reaction conditions. Lowered yields were noticed when 
coupling with 2-iodopyridyl substrates (1y-1aa), where 
dehalogenated pyridines were byproducts. Nonetheless a good 





chemoselectivity between bromo- and iodo-substitutions was 
clearly demonstrated (3aa). 5-Substituted quinolines (3ab and 
3ac) and 4-substituted pyrimidines (3ad and 3ae) were obtained 
in good to excellent yields. Particularly worth noting is with aryl 
bromide 1ae and 1af, the coupling here could be readily achieved 
with bromide substrates using a higher loading of catalyst and an 
elongated residence time to give the desired product 3ae and 3af 
in 80% and 57% yield respectively, while 3af could not be 
obtained from the corresponding iodide. Several other 
heteroaromatic coupling partners, for example carbazole 1ag, 5-
iodoindole 1ah as well as the more reactive 3-iodoindoles 3ai and 
3aj all produced useful results.  
 
 
Figure 3. Scope on heteroaryl halides 
To further exemplify the potential of the reaction, we expanded 
the scope with respect to redox-active ester coupling partners 
using a few different (hetero)aryl iodides (Figure 4). In addition to 
tetrahydropyranyl 2a substrate, other saturated heterocyclic 
examples were also viable coupling partners, including N-boc 
piperidine 1ak and N-cbz piperidine 1al, providing excellent yields 
for the desired C(sp3)-C(sp2) cross-coupling products (3ak and 
3al). Comparable reaction efficiency was also observed with 
carbocyclic examples 3am and 3an. Primary substituted redox-
active esters underwent successful coupling in high yield despite 
the inherent reluctance to generate primary alkyl radicals via 
single-electron-transfer process SET.[19] A series of related 
compounds were generated, including long-chain alkyl chloride 
3ap, mono-(methylacryloylxy)ethyl succinate derivative 3aq, 
pyrene containing  3ar, simple alkene 3as, furan 3at, and amino 
acids 3au and 3av. α-Amino phthalimide esters 1aw-ay that 
generate reactive α-amino C(sp2) species, coupled without 
incident, resulting in high yields of 3aw-ay. Of particular note also 
was that some active pharmaceutical ingredients (APIs) and 
natural products are compatible with the reaction conditions 
affording the anticipated cross-coupled product in good yields 
(3az-bd). Interestingly, the reaction of redox-active ester 2bd 
obtained from gabapentin, provided an unusual product which 
was thought to be generated via a 1,5-hydrogen atom transfer 
(1,5-HAT) prior to nickel mediated cross-coupling (Figure 4a). As 
noted by others,[8d, 9a] the limitation of this procedure was the lack 
of reactivity towards tertiary redox-active esters.[20] Adamantane 
carboxylic acid and tert-butyl carboxylic acid phthalimide ester 
both failed to deliver desired product under our standard 
conditions.   
 
Figure 4. Scope on redox-active esters 
To best demonstrate the advantage of this method was its ability 
to transfer to a larger-scale experiment. Equipped with a longer 
column (i.d.=10.0 mm, length = 120 mm), the reaction set-up was 
kept operating for 31 hours to deliver a 11.77 g target product. 
After the reaction, the remaining zinc was still functional without 
noticeable decline of efficacy. It was also noticed that a small 
amount of bicyclohexyl byproduct was produced, presumably 
from the radical dimerization of redox-active ester.  
 





Scheme 1. 10 g-scale synthesis 
In summary, we have identified a procedurally simple use of a zinc 
packed column as an alternative reductant to photo- or 
electrochemical reactor or organometallic reagents for forging 
C(sp3)-C(sp2) bonds starting from aryl halides and redox-active 
esters. The method is practical and robust, and provides 
enhanced substrate compatibility over previously reported 
examples. Furthermore, the use of crude redox-active esters 
accelerated the synthesis of highly 3D-rich structures from 
carboxylic acids and (hetero)aryl halides. Notably, the work 
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